SEC 13F Intelligence

Mpm Bioimpact LLC / RVMD

Mpm Bioimpact LLC’s Revolution Medicines Inc Position

Does Mpm Bioimpact LLC own Revolution Medicines Inc (RVMD)? Yes506.8K shares worth $49M (+3.81% of its 13F portfolio) as of Q1 2026, up from 505.7K shares the prior filed quarter.

Position Value
$49M
Q1 2026
Shares
506.8K
% of Portfolio
+3.81%
Quarters Held
19
currently held

Position History RVMD

Reported value by quarter
Q3 ’21: $4MQ3 ’21Q4 ’21: $4MQ1 ’22: $4MQ2 ’22: $3MQ2 ’22Q3 ’22: $3MQ4 ’22: $4MQ1 ’23: $5MQ1 ’23Q2 ’23: $7MQ3 ’23: $8MQ4 ’23: $8MQ4 ’23Q1 ’24: $9MQ2 ’24: $11MQ3 ’24: $13MQ3 ’24Q4 ’24: $14MQ1 ’25: $11MQ2 ’25: $12MQ2 ’25Q3 ’25: $15MQ4 ’25: $40MQ1 ’26: $49MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026506.8K$49M+3.81%
Q4 2025505.7K$40M+4.61%
Q3 2025315.7K$15M+2.41%
Q2 2025315.7K$12M+2.01%
Q1 2025317.1K$11M+1.93%
Q4 2024313.8K$14M+1.95%
Q3 2024291.4K$13M+1.98%
Q2 2024289.4K$11M+1.75%
Q1 2024273.2K$9M+1.42%
Q4 2023273.4K$8M+1.83%
Q3 2023273.4K$8M+2.02%
Q2 2023273.4K$7M+1.47%
Q1 2023247.0K$5M+1.39%
Q4 2022149.0K$4M+0.92%
Q3 2022146.0K$3M+0.68%
Q2 2022146.0K$3M+0.79%
Q1 2022146.0K$4M+1.00%
Q4 2021146.0K$4M+0.67%
Q3 2021150.0K$4M+0.64%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mpm Bioimpact LLC’s full portfolio or all institutional holders of RVMD.